Description

Sermorelin (Growth Hormone-Releasing Hormone Analogue)

Description

Sermorelin is a synthetic peptide consisting of the first 29 amino acids of naturally occurring Growth Hormone-Releasing Hormone (GHRH). It is studied for its ability to stimulate the pituitary gland to release endogenous growth hormone (GH), which plays an important role in growth, metabolism, and tissue maintenance.

Unlike synthetic growth hormone, Sermorelin acts through the body’s natural growth hormone signaling pathway. It is investigated for its effects on growth hormone secretion, insulin-like growth factor-1 (IGF-1) production, metabolic regulation, and age-related changes in hormone activity.

Key benefits (research findings)

Stimulates endogenous growth hormone secretion through activation of GHRH receptors in the pituitary gland.

May increase IGF-1 production through growth hormone signaling pathways.

Studied for its potential effects on protein metabolism, tissue maintenance, and body composition.

Investigated for its role in age-related changes in growth hormone secretion and endocrine function.

May support research into sleep-associated growth hormone secretion and natural hormonal rhythms.

Clinical evidence is strongest for its ability to stimulate growth hormone release. Benefits involving recovery, sleep, anti-aging, and body composition have not been conclusively established.

Who it’s for

Researchers investigating growth hormone physiology, pituitary function, endocrine regulation, and metabolic pathways.

Intended strictly for laboratory and investigational use; not for individual or unsupervised administration.

Suggested use

Utilized in controlled research environments according to established study protocols.

Experimental concentrations, administration methods, and study schedules vary depending on research objectives and experimental design.

Follow all laboratory guidelines and compound-specific research protocols when handling Sermorelin.

Safety and storage

Reported adverse effects in clinical research include injection-site irritation, flushing, headache, dizziness, and transient changes in hormone levels.

Because Sermorelin influences growth hormone and IGF-1 signaling, researchers should consider potential effects on glucose regulation and other endocrine pathways.

Store according to manufacturer or protocol recommendations, typically refrigerated when specified and protected from light and moisture. Storage requirements may differ between lyophilized and prepared formulations.

Proper laboratory safety procedures and sterile handling techniques should always be followed.

Quick facts

Mechanism: Growth Hormone-Releasing Hormone (GHRH) receptor agonist that stimulates endogenous growth hormone secretion.

Peptide structure: Synthetic 29-amino-acid peptide corresponding to the biologically active portion of human GHRH.

Status: Sermorelin was previously FDA-approved in certain prescription formulations, but those products were discontinued. Sermorelin is not currently available as an FDA-approved marketed drug in the United States.

Studied for: Growth hormone secretion, IGF-1 regulation, pituitary function, endocrine aging, metabolism, and body composition.

Distinction: Unlike CJC-1295 with DAC, Sermorelin does not contain a Drug Affinity Complex and has a relatively short duration of action.

Research Use Only Disclaimer

Products sold by SoCo Peptides are intended strictly for laboratory research purposes only.

These compounds are not intended for human consumption, veterinary use, household use, cosmetic use, or therapeutic application. They are not drugs, foods, or dietary supplements and have not been evaluated or approved by the FDA.

By purchasing from this website, the customer represents that they are a qualified researcher or laboratory professional and understand the risks associated with handling research materials.

All products must be handled by trained professionals in appropriate research facilities and in accordance with all applicable laws and regulations.

SoCo Peptides makes no guarantees or claims regarding safety, effectiveness, or medical benefit.